PHA-Exch> Health Partnerships Review: Focusing collaborative efforts on research and innovation for the health of the poor

[Claudio Schuftan]

From: Ruggiero, Mrs. Ana Lucia (WDC) <ruglucia at paho.org>
crossposted from: EQUIDAD at listserv.paho.org

*Health Partnerships Review: Foc**using collaborative efforts on research
and innovation for the health of the poor.  ** **Global Forum for Health
Research 2008*

* *Available online as PDF file [102p.] at:
http://www.globalforumhealth.org/filesupld/hpr/HealthPartnershipsReview_Full.pdf

 "The poor die young. Data from every part of the world show that, whether
comparing richer and poorer populations within or between countries, those
that are least well off have shorter life expectancies and heavier burdens
of disease than those that are relatively wealthy. While the highest
attainable standard of health has been declared  a human right, this health
inequity reflects a collective neglect at national and global levels –
neglect of diseases, of health systems and ultimately of people…."

"….Three areas of failure can be highlighted that represent different
dimensions of the problem – failures of science (where basic knowledge or
tools are lacking), failures of the market (where economic incentives for
the production of needed medicines are lacking), and public health failures
(where systems and programmes to implement available interventions are
lacking)…." *From Stephen Matlin, Executive Director, Global Forum for
Health Research*

"…..Over the last few years, partnerships between public and private sector
organizations have become an increasingly common mechanism to address some
of the diseases of the poor in developing countries.

The ultimate goal of most of these partnerships is to improve and increase
access to treatment, particularly for 'neglected diseases'. Many also
express the goal of contributing to the alleviation of poverty through
improved health.

The need for such partnerships can be explained by a failure of public
health systems – the inability of the public sector to provide public goods
entirely on its own, due to lack of resources; competing priorities for the
limited resources available; management issues; conflict and post-conflict
situations; etc. There is also a failure on the part of the private sector
when there is little or no commercial incentive for the development of
diagnostics and medicines for most of the diseases endemic in developing
countries and affecting mainly the very poor…"

*Does anybody care to comment on this
foreword?     Claudio
                               *

*Contents*

Foreword  Stephen Matlin

*Focusing collaborative efforts on research and innovation for the health of
the poor*

The PDP approach

*
The new landscape of product development partnerships (PDPs)*

Stefanie Meredith and Elizabeth Ziemba

*
Public–private partnerships in health systems - *Sania Nishtar

*
Issues in assessing product development partnerships (PDPs) - *Lakshmi
Sundaram

*
Technological and social innovation: a unifying new paradigm for global
health*

Charles A Gardner, Tara Acharya and Derek Yach

*
Product development partnerships: public–private partnerships among unequal
partners?*

Anna Wang




*Research and development*

*Facing the dual challenge of developing both products and research
capacities for neglected diseases*

Piero L Olliaro and Stephen C Wayling

*
The portfolio approach to successful product development in global health -
*David Brown

*
The role of the health system in biotechnology in Brazil and Cuba - *Halla
Thorsteinsdóttir

*
Sustainable (vaccine) development: the International AIDS Vaccine Initiative
(IAVI) and capacity building*

Joanna Chataway and Rebecca Hanlin

*
Beyond market failures: IAVI and the organizational challenges of vaccine
development*

Luigi Orsenigo, Stefano Brusoni and Eugenia Cacciatori




*Clinical trials*

*Clinical trial site capacity for malaria product development*

Mary Moran, Javier Guzman, Anne-Laure Ropars, Margaret Jorgensen, Sarah
Potter, Alina McDonald and Hiwot Haile-Selassie

*
Issues surrounding the implementation of multiple product development
partnership clinical trials in developing countries*

Gita Ramjee

*
Collaborative approach to clinical trials - *Charles S Mgone and Pascoal
Mocumbi

*
Running clinical trials in partnership with communities - *Anjali Gopalan

* *

*Bringing products to market*

*Getting diagnostics into countries - *Vinand M Nantulya

*
The control of neglected tropical diseases using access to available
medicines through public–private partnerships*

Alan Fenwick, Peter J Hotez and David H Molyneux

*
The story of ASAQ: the first antimalarial product development partnership
success*

Bernard Pécoul, Ann-Marie Sevcsik, John Amuasi, Graciela Diap and Jean-René
Kiechel

*
Managing intellectual property for global health outcomes: the example of
product development partnerships*

Robert Eiss

*
Regulatory strategies of product development partnerships: some perspectives
*

Chris Hentschel, Jörg Möhrle and Jaya Banerji
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://phm.phmovement.org/pipermail/phm-exchange-phmovement.org/attachments/20080808/5f1eac4b/attachment-0001.html>